[New announcement] 27,500 Pharma and Biotech Execs Read This Daily

Hi All,

A few months ago, I told you about a new publication in the biotech and pharma space that I found greatly valuable, BioPharma Dive. In their regular news coverage, they have a "brief" format that saves a lot of time -- three bullets of facts and an insights section that connect the dots. Their feature articles also top the industry best: just this week they covered the JP Morgan Healthcare Conference and ran an exclusive interview with Sanofi's EVP.

Since launch last year, BioPharma Dive has grown to more than 27,500 readers, including senior execs from GSK, Amgen, Genentech, Biogen Idec, Novartis, Pfizer, AbbVie, Roche, and more. I am bumping this up to offer the group a free subscription.

Activate your subscription here: http://bit.ly/BD-IHRoffer

BioPharma Dive covers:

- FDA Approvals and Regulations
- Drug Discovery
- Clinical Trials
- Mergers & Acquisitions
- Licensing Deals
- Drug Pipelines
- Pharma Marketing
- and More

You'll also gain access to a calendar of top industry events and a job board of the latest industry careers. Oh, and it is mobile-optimized so it is really helpful to read on my phone or visit the site when I'm on the road.

Sign up for free today: http://bit.ly/BD-IHRoffer

Best,
Paul Healy
Group Manager

Groups Announcement in Pharmaceutical Jobs Biotech Life Science Healthcare Pharma & Medical Devices Careers HR Recruitment 27,500 Pharma and Biotech Execs Read This Daily Paul Healy Director, International Healthcare Recruitment [IHR] Hi All, A few months ago, I told you about a new publication in the biotech and pharma space that I found greatly valuable, BioPharma Dive. In their regular news coverage, they have a "brief" format that saves a lot of time -- three bullets of facts and an insights section that connect the dots. Their feature articles also top the industry best: just this week they covered the JP Morgan Healthcare Conference and ran an exclusive interview with Sanofi's EVP. Since launch last year, BioPharma Dive has grown to more than 27,500 readers, including senior execs from GSK, Amgen, Genentech, Biogen Idec, Novartis, Pfizer, AbbVie, Roche, and more. I am bumping this up to offer the group a free subscription. Activate your subscription here: http://bit.ly/BD-IHRoffer BioPharma Dive covers: - FDA Approvals and Regulations - Drug Discovery - Clinical Trials - Mergers & Acquisitions - Licensing Deals - Drug Pipelines - Pharma Marketing - and More You'll also gain access to a calendar of top industry events and a job board of the latest industry careers. Oh, and it is mobile-optimized so it is really helpful to read on my phone or visit the site when I'm on the road. Sign up for free today: http://bit.ly/BD-IHRoffer Best, Paul Healy Group Manager Respond Now View   Don't want to hear from the manager? Unsubscribe here This email was intended for Muhammad Hatta (Manager and Pediatrician at Lina Clinic Tanjungbalai). Learn why we included this. If you need assistance or have questions, please contact LinkedIn Customer Service. © 2014 LinkedIn Ireland, Gardner House, Wilton Plaza, Wilton Place, Dublin 2, Ireland